Denali Therapeutics Target Price

Where could DNLI trade next? Consensus target price: $33.

Get informed when a big investor buys or sells

+ Follow

Share Price

$24.31

Average Target Price

$32.50

33.7% upside

8 analysts in the last 4 months

High: $41 | Low: $23

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	UBS	$34	39.9% upside
2026-08-07	Robert W. Baird	$34	39.9% upside
2026-07-23	Morgan Stanley	$36	48.1% upside
2026-07-13	WedbushLaura Chico	$26	7% upside
2026-06-22	Stifel NicolausPaul Mattels	$41	68.7% upside
2026-05-22	Morgan Stanley	$35	44% upside
2026-05-22	Deutsche Bank	$31	27.5% upside
2026-05-08	WedbushLaura Chico	$23	5.4% downside
2026-03-26	Deutsche Bank	$35	44% upside
2026-03-02	JefferiesAndrew Tsai	$40	64.5% upside
2026-01-08	Morgan StanleySean Laaman	$40	64.5% upside
2026-01-07	UBSMichael Yee	$25	2.8% upside
2025-12-11	WedbushLaura Chico	$30	23.4% upside
2025-12-05	WedbushLaura Chico	$31	27.5% upside
2025-11-17	Stifel NicolausPaul Mattels	$37	52.2% upside
2025-01-07	BTIGThomas Shrader	$32	31.6% upside
2024-11-01	JefferiesMichael Yee	$45	85.1% upside
2024-10-14	BTIGThomas Shrader	$35	44% upside
2024-09-04	Bank of America SecuritiesTazeen Ahmad	$29	19.3% upside
2024-09-03	B.Riley FinancialMarank Mamtani	$33	35.7% upside
2024-09-03	Goldman SachsSalveen Richter	$46	89.2% upside
2024-09-03	Stifel NicolausPaul Mattels	$22	9.5% downside
2021-08-05	Goldman SachsSalveen Richter	$112	360.7% upside
2021-05-18	UBSEsther Rajavelu	$70	187.9% upside

Denali Therapeutics (DNLI) FAQ

The latest target price for DNLI is $33. Investors often review this figure alongside Denali Therapeutics's historical trend and sector peers before judging valuation or financial health.

Denali Therapeutics trades near $24.31 while the consensus target sits at $33 (33.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting DNLI's target price ($33), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Denali Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.